John Andrew Dawson
Director · PDS Biotechnology Corp
Individual
- 2026
- Oct 21, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at John Andrew Dawson's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Larry Robbins - $46.04M in BFLY purchases and sales in the last 12 months
- R01 Fund LP - $45.65M in SDEV purchases and sales in the last 12 months
- Michael John Kazley - $45.65M in SDEV purchases and sales in the last 12 months
- Stephen Hoge - $45.45M in MRNA purchases and sales in the last 12 months
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- James C. Foster - $43.26M in CRL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John Andrew Dawson?
John Andrew Dawson is a corporate insider, tracked as Director of PDS Biotechnology Corp (PDSB). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John Andrew Dawson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.